The Shenzhen Small and Medium sized Enterprise Service Bureau has officially announced the list of "Specialized, Refined, Unique and New" small and medium-sized enterprises in Shenzhen for 2024. Shenzhen Sungening Biotechnology Co., Ltd. (hereinafter referred to as "Sungening Biotechnology") has been selected for its international leading technology in the research and development of cyclic peptide drugs and innovative antifungal drugs! This evaluation marks a new stage for Sungening Biotechnology on the development path of "specialization, refinement, specialization, and novelty", further demonstrating Sungening Biotechnology's innovative competitiveness in technology and pipelines.
Sungening Biotechnology will take this opportunity to obtain specialized and innovative qualifications, further strengthen research and development investment, attract and cultivate more outstanding professional talents, and inject new impetus into the company's sustainable development. At the same time, Sungening Biotechnology will actively expand domestic and international markets, strengthen cooperation and exchanges with domestic and foreign research institutions and enterprises, promote the transformation and application of innovative drug research and development achievements, contribute to the development of the biopharmaceutical industry, and move towards the goal of becoming a leading enterprise in the global innovative drug research and development field!
Specialized, refined, distinctive, and innovative "mainly refers to small and medium-sized enterprises with four major advantages of specialization, refinement, distinctiveness, and novelty. They are key technology-based enterprises supported and supported by the state. It is not just a label, but also a high recognition of the comprehensive strength of the enterprise. We will continue to maintain our professional spirit, set sail, and create more value for society!
